Opening book details…
About this book
Semaglutide in Patients with Overweight or Obesity and Chronic Kidney Disease Without Diabetes: a Randomized Double-blind Placebo-controlled Clinical Trial by Ellen M. Apperloo & Jose L. Gorriz & Maria Jose Soler & Secundino Cigarrán Guldris & Josep M. Cruzado & Maria Jesús Puchades & Marina López-Martínez & Femke Waanders & Gozewijn D. Laverman & Annemarie Aart-van der Beek & Klaas Hoogenberg & André P.... is a book available to read on EtoBox.
- Author
- Ellen M. Apperloo & Jose L. Gorriz & Maria Jose Soler & Secundino Cigarrán Guldris & Josep M. Cruzado & Maria Jesús Puchades & Marina López-Martínez & Femke Waanders & Gozewijn D. Laverman & Annemarie Aart-van der Beek & Klaas Hoogenberg & André P....
- Publisher
- Springer US
- Published
- 2025
- Language
- EN
More by Ellen M. Apperloo & Jose L. Gorriz & Maria Jose Soler & Secundino Cigarrán Guldris & Josep M. Cruzado & Maria Jesús Puchades & Marina López-Martínez & Femke Waanders & Gozewijn D. Laverman & Annemarie Aart-van der Beek & Klaas Hoogenberg & André P....
Similar books
- Subcutaneous Weekly Semaglutide with Automated Insulin Delivery in Type 1 Diabetes: a Double-blind, Randomized, Crossover Trial — Melissa-Rosina Pasqua & Michael A. Tsoukas & Alessandra Kobayati & Wedyan Aboznadah & Adnan Jafar & Ahmad Haidar (2025)
- Low-dose Spironolactone and Cardiovascular Outcomes in Moderate Stage Chronic Kidney Disease: a Randomized Controlled Trial — F. D. Richard Hobbs & Richard J. McManus & Clare J. Taylor & Nicholas R. Jones & Joy K. Rahman & Jane Wolstenholme & Sungwook Kim & Joseph Kwon & Louise Jones & Jennifer A. Hirst & Ly-Mee Yu & Sam Mort & R. J. McManus & L. Jones & B. Thompson & J. K.... (2024)
- Garetosmab in Fibrodysplasia Ossificans Progressiva: a Randomized, Double-blind, Placebo-controlled Phase 2 Trial — Maja Rocco & Eduardo Forleo-Neto & Robert J. Pignolo & Richard Keen & Philippe Orcel & Thomas Funck-Brentano & Christian Roux & Sami Kolta & Annalisa Madeo & Judith S. Bubbear & Jacek Tabarkiewicz & Maamp#x00142; gorzata Szczepanek & Javier... (2023)
- Ustekinumab for Type 1 Diabetes in Adolescents: a Multicenter, Double-blind, Randomized Phase 2 Trial — Danijela Tatovic & Ashish Marwaha & Peter Taylor & Stephanie J. Hanna & Kym Carter & W. Y. Cheung & Steve Luzio & Gareth Dunseath & Hayley A. Hutchings & Gail Holland & Steve Hiles & Greg Fegan & Evangelia Williams & Jennie H. M. Yang & Clara... (2024)
- Dupilumab in Patients with Prurigo Nodularis: Two Randomized, Double-blind, Placebo-controlled Phase 3 Trials — Gil Yosipovitch & Nicholas Mollanazar & Sonja Ständer & Shawn G. Kwatra & Brian S. Kim & Elizabeth Laws & Leda P. Mannent & Nikhil Amin & Bolanle Akinlade & Heribert W. Staudinger & Naimish Patel & George D. Yancopoulos & David M. Weinreich & Sheldon... (2023)
- Resmetirom for Nonalcoholic Fatty Liver Disease: a Randomized, Double-blind, Placebo-controlled Phase 3 Trial — Stephen A. Harrison & Rebecca Taub & Guy W. Neff & K. Jean Lucas & Dominic Labriola & Sam E. Moussa & Naim Alkhouri & Mustafa R. Bashir (2023)